PRCT Investors Have Opportunity to Join PROCEPT BioRobotics Corporation Fraud Investigation with the Schall Law Firm

Core Viewpoint - The Schall Law Firm is investigating claims against PROCEPT BioRobotics Corporation for potential violations of securities laws due to misleading statements and undisclosed information affecting investors [1][2]. Group 1: Investigation Details - The investigation centers on whether PROCEPT BioRobotics issued false or misleading statements and failed to disclose critical information to investors [2]. - The company reported Q4 2025 financial results on February 25, 2026, revealing quarterly revenue significantly below analyst expectations and a substantial cut in full-year revenue guidance [2]. - The decline in performance was attributed to disruptions from a realignment and the removal of bulk-purchase discounts, leading to a more than 15.1% drop in share price the following day [2]. Group 2: Shareholder Information - Shareholders who experienced losses are encouraged to participate in the investigation and can contact the Schall Law Firm for a free discussion of their rights [3]. - The Schall Law Firm specializes in securities class action lawsuits and represents investors globally [3].